Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Flash glucose monitoring (Flash GM) is a new technology which has become popular amongst people with diabetes, despite not yet being available on the NHS. So popular, that many people are self-funding the technology. However, many people with diabetes who could benefit from using the technology are unable to afford it. A recent publication has shown that use of Flash GM is largely limited to more affluent people 1 . This is leading to inequalities in access.
“We are lucky to be able to afford the Libre, it has made a huge difference to my daughter’s lifestyle and her diabetes care. It’s a travesty that those who can’t afford it don’t have access to such a life changing technology.” Emma, mother of a child with Type 1 diabetes
We have developed these recommendations for the use of Flash GM in the NHS, jointly with other diabetes organisations representing people with diabetes and clinicians. We recognise that there is need for further research and audit to determine a full picture of the benefits and limitations of the technology to the NHS and people with diabetes. These recommendations are based on the best currently available clinical and scientific evidence as well as experiences from people living with diabetes using this technology.
https://www.diabetes.org.uk/Documents/campaigning/1190_Flash glucose monitoring guideline_SB_V8.pdf
“We are lucky to be able to afford the Libre, it has made a huge difference to my daughter’s lifestyle and her diabetes care. It’s a travesty that those who can’t afford it don’t have access to such a life changing technology.” Emma, mother of a child with Type 1 diabetes
We have developed these recommendations for the use of Flash GM in the NHS, jointly with other diabetes organisations representing people with diabetes and clinicians. We recognise that there is need for further research and audit to determine a full picture of the benefits and limitations of the technology to the NHS and people with diabetes. These recommendations are based on the best currently available clinical and scientific evidence as well as experiences from people living with diabetes using this technology.
https://www.diabetes.org.uk/Documents/campaigning/1190_Flash glucose monitoring guideline_SB_V8.pdf